paper: integrate calibrated oral-B-v2 evidence

1 files changed, 26 insertions, 7 deletions

diff --git a/README.md b/README.md
index b6782cc..b5ec4d4 100644
--- a/README.md
+++ b/README.md
@@ -82,7 +82,7 @@ and scaling behavior. See `NOVELTY.md` for the exact prior-art boundary.
   `0.999687`, and all trajectory, projection, leakage, query, hardware, MAC,
   memory, split, and test-isolation checks pass.  This untouched confirmation
   establishes the strict 7/10 accept bar; it does not establish that added
-  standard-network depth is useful or repair the failed biological signatures.
+  standard-network depth is useful.
 - Native author-code fidelity is complete. BurstCCN reaches `80.10%` at its
   validation-selected epoch versus published `82.97 +/- 0.21%`; Dual Prop
   reaches `92.46%` versus published `92.41 +/- 0.07%`. Their audited walls are
@@ -108,6 +108,20 @@ works in this synthetic task, but the broader Harnett-like population
 vectorization signature is not established. The strict score remains 7/10
 and the oral-A depth panel stays sealed.
 
+An independent oral-B-v2 then adds an explicit terminal reward/timeout phase,
+a local linear TD critic, and temporal eligibility traces. Its first frozen
+grid is retained as a cold-start failure, and a fixed-target recovery is
+retained after one new seed remains at ceiling. The final algorithm is frozen
+before a label-free psychometric calibration: cursor-max quantiles from 512
+outcome-free trials define targets for independent rewarded/timeout trials.
+The complete untouched 6-task by 5-model confirmation passes every clustered
+gate: 100% task success, 0.976 mean learned-role cosine, 0.063
+residual--soma correlation, 54.37% surrounding-state decoding, 50.09%
+rewarded trials, 99.83% terminal outcome decoding, a 0.400 acute outcome-lesion
+drop in role separation, and 30/30 positive causal signs. This raises the
+formal milestone to 8/10 and permits only a separately frozen oral-A-v2
+protocol; the old depth panel remains closed.
+
 ## Publication-facing artifacts
 
 - `RESULTS.md`: audited positive and negative results;
@@ -120,6 +134,9 @@ and the oral-A depth panel stays sealed.
   frozen D1--D4 gates;
 - `ORAL_B_RECOVERY.md`: structural diagnosis and mechanics-only temporal-
   difference recovery boundary;
+- `ORAL_B_V2.md`, `ORAL_B_V2_RECOVERY.md`, and
+  `ORAL_B_V2_CALIBRATED_RECOVERY.md`: retained v2 failures and the passed
+  label-free calibrated outcome-surprise protocol;
 - `ORAL_A.md`: frozen standard CIFAR ResNet funnel;
 - `ORAL_A_V2.md`: frozen post-failure representable-subspace funnel;
 - `ORAL_A_V3.md`: frozen vectorizer-space causal-calibration funnel;
@@ -129,8 +146,8 @@ and the oral-A depth panel stays sealed.
   from manuscript numbers, gate statuses, figures, and claim boundaries to
   their audited source files;
 - `results/figs/`: deterministic PDF/PNG main figures, captions, and a source
-  hash manifest, including the untouched D4 ResNet-20 confirmation, plus
-  audited RRM failure and dynamic-stability supplements.
+  hash manifest, including the untouched D4 ResNet-20 and oral-B-v2
+  confirmations, plus audited RRM failure and dynamic-stability supplements.
 
 The current main figures show the local-method Pareto frontier, credit
 assignment versus depth, the load-bearing innovation ablation, and the
@@ -234,7 +251,9 @@ accounting, and final finiteness. Development, validation, and untouched
 confirmation results are never pooled. Failed gates close their branch instead
 of triggering seed deletion or post-hoc threshold changes.
 
-The current strict reviewer estimate is `5/10` (borderline reject, confidence
-`4/5`): the mechanism and controlled depth-preservation results are strong,
-but the frozen standard-useful-scale attempt failed. The score changes only
-after an audited frozen stage, not after a pilot or a presentation improvement.
+The current formal milestone is `8/10` (accept, confidence `4/5`) after the
+untouched D4 and oral-B-v2 confirmations. A conservative external-review
+forecast is `7/10`: positive added-depth utility, original-data biological
+validation, and a credit pathway novel beyond inherited perturbation/KP
+mechanisms remain open. Scores change only after an audited frozen stage, not
+after a pilot or presentation improvement.